Identification of Withaferin A as a Potential Candidate for Anti-Cancer Therapy in Non-Small Cell Lung Cancer
Low response rate and recurrence are common issues in lung cancer; thus, identifying a potential compound for these patients is essential. Utilizing an in silico screening method, we identified withaferin A (WA), a cell-permeable steroidal lactone initially extracted from <i>Withania somnifera...
Main Authors: | Jade H.-M. Hsu, Peter M.-H. Chang, Tai-Shan Cheng, Yu-Lun Kuo, Alexander T.-H. Wu, Thu-Ha Tran, Yun-Hsuan Yang, Jing-Ming Chen, Yu-Chen Tsai, Yeh-Shiu Chu, Tse- Hung Huang, Chi-Ying F. Huang, Jin-Mei Lai |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/7/1003 |
Similar Items
-
Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives
by: Tapan Behl, et al.
Published: (2020-12-01) -
Withaferin-A Can Be Used to Modulate the Keratin Network of Intermediate Filaments in Human Epidermal Keratinocytes
by: Michael C. Keeling, et al.
Published: (2020-06-01) -
Withaferin A inhibits osteosarcoma cells through inactivation of Notch-1 signalling
by: Yang Chen, et al.
Published: (2014-08-01) -
Withaferin a Triggers Apoptosis and DNA Damage in Bladder Cancer J82 Cells through Oxidative Stress
by: Tsu-Ming Chien, et al.
Published: (2021-06-01) -
Computational Identification of BCR-ABL Oncogenic Signaling as a Candidate Target of Withaferin A and Withanone
by: Vidhi Malik, et al.
Published: (2022-01-01)